192 related articles for article (PubMed ID: 9669203)
1. The immunopharmacology of head and neck cancer: an update.
Hadden JW
Int J Immunopharmacol; 1997; 19(11-12):629-44. PubMed ID: 9669203
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of head and neck cancer.
Resser JR; Carbone DP
Curr Opin Oncol; 1998 May; 10(3):226-32. PubMed ID: 9619359
[TBL] [Abstract][Full Text] [Related]
3. Generation of therapeutic T cells from draining lymph nodes in a murine model of head and neck squamous cell carcinoma.
Sadeghi N; Black MJ; Hier MP; Shenouda G; Karp SE
Arch Otolaryngol Head Neck Surg; 1997 Jan; 123(1):25-30. PubMed ID: 9006500
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
5. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma.
Kerrebijn JD; Simons PJ; Balm AJ; Tas M; Knegt PP; de Vries N; Tan IB; Drexhage HA
Head Neck; 1996; 18(4):335-42. PubMed ID: 8780944
[TBL] [Abstract][Full Text] [Related]
6. Immunology of head and neck cancers.
Newbill ET; Johns ME
Crit Rev Clin Lab Sci; 1983; 19(1):1-25. PubMed ID: 6201320
[TBL] [Abstract][Full Text] [Related]
7. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?
Ferris RL
ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):332-40. PubMed ID: 15668533
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
9. Covalent linking of proteins and cytokines to suture: enhancing the immune response of head and neck cancer patients.
Shibuya TY; Kim S; Nguyen K; Parikh P; Wadhwa A; Brockardt C; Do J
Laryngoscope; 2003 Nov; 113(11):1870-84. PubMed ID: 14603040
[TBL] [Abstract][Full Text] [Related]
10. Interleukins and contrasuppression induce immune regression of head and neck cancer.
Hadden JW; Endicott J; Baekey P; Skipper P; Hadden EM
Arch Otolaryngol Head Neck Surg; 1994 Apr; 120(4):395-403. PubMed ID: 8166968
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of head and neck cancer using tumor antigen-specific monoclonal antibodies.
Lee SC; López-Albaitero A; Ferris RL
Curr Oncol Rep; 2009 Mar; 11(2):156-62. PubMed ID: 19216848
[TBL] [Abstract][Full Text] [Related]
12. Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.
Moy JD; Moskovitz JM; Ferris RL
Eur J Cancer; 2017 May; 76():152-166. PubMed ID: 28324750
[TBL] [Abstract][Full Text] [Related]
13. Immunodeficiency and cancer: prospects for correction.
Hadden JW
Int Immunopharmacol; 2003 Aug; 3(8):1061-71. PubMed ID: 12860163
[TBL] [Abstract][Full Text] [Related]
14. The immunology and immunotherapy of breast cancer: an update.
Hadden JW
Int J Immunopharmacol; 1999 Feb; 21(2):79-101. PubMed ID: 10230872
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for Head and Neck Squamous Cell Carcinoma.
Schoppy DW; Sunwoo JB
Hematol Oncol Clin North Am; 2015 Dec; 29(6):1033-43. PubMed ID: 26568546
[TBL] [Abstract][Full Text] [Related]
16. Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma.
Wang MB; Lichtenstein A; Mickel RA
Otolaryngol Head Neck Surg; 1991 Oct; 105(4):517-27. PubMed ID: 1762790
[TBL] [Abstract][Full Text] [Related]
17. Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma.
Sun W; Li WJ; Wei FQ; Wong TS; Lei WB; Zhu XL; Li J; Wen WP
Oncotarget; 2016 Jun; 7(25):37714-37727. PubMed ID: 27177223
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
Bron L; Romero P
Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
[TBL] [Abstract][Full Text] [Related]
19. Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma.
Almokadem S
Curr Mol Pharmacol; 2016; 9(3):226-230. PubMed ID: 26177644
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.
Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo G; June CH; Levine B; Lum LG
Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1229-34. PubMed ID: 10555694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
